Neel Shah, MD, MMP shares his thoughts on the ARRIVE Trial. Dr. Shah is recognized as an innovative leader in maternal-infant health and a well-respected expert on effective methods for reducing the cesarean rate in the U.S.
Henci Goer examines the just-released ARRIVE Trial to determine if there is new information compared to the study abstract that raises more questions or answers the old ones? What should birth professionals understand and share with consumers about the evidence to induce at 39 weeks?
The findings in a new Cochrane review continue to confirm laboring and birthing in water is a safe and acceptable option for those who choose it. It is important to examine this issue as new information becomes available. Waterbirth continues to a safe and healthy option for families.
A small but very positive study just released has demonstrated the ability to determine gestational age with a blood test as accurately as early ultrasound. Subsequent blood tests during the pregnancy appear to be accurate in determining who is at risk of delivering prematurely.
A just-published study shows that not only is it important what hospital a person chooses to give birth in, it is also very important to choose a provider whose attitudes favor vaginal births for their patients and clients.